Xiwu Lin

1.2k total citations
43 papers, 790 citations indexed

About

Xiwu Lin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Hematology. According to data from OpenAlex, Xiwu Lin has authored 43 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 10 papers in Hematology. Recurrent topics in Xiwu Lin's work include Multiple Myeloma Research and Treatments (9 papers), Asthma and respiratory diseases (7 papers) and Gene expression and cancer classification (5 papers). Xiwu Lin is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Asthma and respiratory diseases (7 papers) and Gene expression and cancer classification (5 papers). Xiwu Lin collaborates with scholars based in United States, United Kingdom and Belgium. Xiwu Lin's co-authors include Héctor Ortega, Patrick Lefèbvre, Mark Forshag, Laurence Gozalo, Marie-Noëlle Robitaille, Anand A. Dalal, Frank C. Albers, Steve Yancey, Mei Sheng Duh and Dong Xiang and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Xiwu Lin

37 papers receiving 764 citations

Peers

Countries citing papers authored by Xiwu Lin

Since Specialization

Citations

This map shows the geographic impact of Xiwu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiwu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiwu Lin more than expected).

Fields of papers citing papers by Xiwu Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiwu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiwu Lin. The network helps show where Xiwu Lin may publish in the future.

Co-authorship network of co-authors of Xiwu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiwu Lin. A scholar is included among the top collaborators of Xiwu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiwu Lin. Xiwu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study 2025 ·Lung Cancer ·C. Chouaïd, L. Bosquet, Craig Knott, (unknown), (unknown), Xiwu Lin, (unknown), (unknown), Joris Diels, Esther Caparrós, Francesca Galea, Agnes Hultén, Alastair Greystoke	0
2	Population‐based study of disease trajectory after radical treatment for high‐risk prostate cancer 2024 ·British Journal of Urology ·Pär Stattin, (unknown), Xiwu Lin, Florence Lefresne, Sabine Brookman‐May, Suneel Mundle, (unknown), Dina Gifkins, David Robinson, Johan Styrke, Hans Garmo	0
3	P-099 Updated Comparative Effectiveness of Talquetamab vs Real-world Physician's Choice of Treatment in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Jing Christine Ye, Noa Biran, Sandhya Nair, Xiwu Lin, Keqin Qi, Eric M. Ammann, Thomas Renaud, Colleen Kane, Trilok Parekh, Kathleen Gray, Xinke Zhang, Luciano da Fontoura Costa	1
4	Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database 2024 ·Blood Cancer Journal ·S. Vincent Rajkumar, María‐Victoria Mateos, (unknown), Xiwu Lin, (unknown), (unknown), Annette Lam, Robin Carson, (unknown), Shuchita Kaila, (unknown), (unknown), Sagar Lonial	0
5	Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Jing Christine Ye, Noa Biran, Sandhya Nair, Xiwu Lin, Keqin Qi, Anil Londhe, Eric M. Ammann, Thomas Renaud, Colleen Kane, Trilok Parekh, Kathleen Gray, (unknown), Luciano J. Costa	0
6	Teclistamab versus real-world physician’s choice of therapy in triple-class exposed relapsed/refractory multiple myeloma 2023 ·Journal of Comparative Effectiveness Research ·Amrita Krishnan, Ajay K. Nooka, Ajai Chari, Alfred L. Garfall, Thomas G. Martin, Sandhya Nair, Xiwu Lin, Keqin Qi, Anil Londhe, Lixia Pei, Eric M. Ammann, Rachel Kobos, Jennifer Smit, Trilok Parekh, (unknown), (unknown), Saad Z. Usmani	8
7	A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients 2023 ·World Journal of Urology ·Stephen J. Freedland, Sandhya Nair, Xiwu Lin, Lawrence I. Karsh, Christopher Pieczonka, Ravi Potluri, Sabine Brookman‐May, Suneel Mundle, (unknown), Neeraj Agarwal	1
8	Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response 2021 ·The Journal of Clinical Psychiatry ·Ibrahim Turkoz, Ella Daly, Jaskaran Singh, Xiwu Lin, Yevgen Tymofyeyev, (unknown), Giacomo Salvadore, Abigail I. Nash, Matthew Macaluso, Samuel T. Wilkinson, J. Craig Nelson	17
9	Reliability, validity and responsiveness of E-RS:COPD in patients with spirometric asthma-COPD overlap 2019 ·Respiratory Research ·Linda Nelsen, Laurie A. Lee, Wei Wu, Xiwu Lin, Lindsey Murray, Steven Pascoe, Nancy Kline Leidy	6
10	Long‐Term Impact of Belimumab on Health‐Related Quality of Life and Fatigue in Patients With Systemic Lupus Erythematosus: Six Years of Treatment 2018 ·Arthritis Care & Research ·Vibeke Strand, Pamela Berry, Xiwu Lin, Yumi Asukai, (unknown), Sulabha Ramachandran	35
11	Humanistic outcomes in treatment resistant depression: a secondary analysis of the STARD study 2018 ·BMC Psychiatry* ·Allitia DiBernardo, Xiwu Lin, Qiaoyi Zhang, Jim Xiang, (unknown), Carol Jamieson, Carmela Benson, Kwan Lee, Robert Bodén, Lena Brandt, Philip Brenner, Johan Reutfors, Gang Li	48
12	The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada 2017 ·Canadian Respiratory Journal ·Tam Dang‐Tan, Shiyuan Zhang, (unknown), (unknown), Afisi Ismaila, Julie Vaillancourt, (unknown), Richard H. Stanford, Xiwu Lin, Gilbert Nadeau, (unknown), Daria Parsons, John S. Sampalis	5
13	The impact of long-term systemic glucocorticoid use in severe asthma: A UK retrospective cohort analysis 2017 ·Journal of Asthma ·(unknown), Xiwu Lin, (unknown), Robert Suruki, Eric Bradford	40
14	Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group 2015 ·Journal of Managed Care & Specialty Pharmacy ·Richard H. Stanford, Saurabh Nagar, Xiwu Lin, Richard D. O’Connor	2
15	Acute and chronic systemic corticosteroid–related complications in patients with severe asthma 2015 ·Journal of Allergy and Clinical Immunology ·Patrick Lefèbvre, Mei Sheng Duh, Marie‐Hélène Lafeuille, Laurence Gozalo, Urvi Desai, Marie-Noëlle Robitaille, Frank C. Albers, Steve Yancey, Héctor Ortega, Mark Forshag, Xiwu Lin, Anand A. Dalal	158
16	Validation of Multivariate Outlier Detection Analyses Used to Identify Potential Drug-Induced Liver Injury in Clinical Trial Populations 2012 ·Drug Safety ·Xiwu Lin, Daniel Parks, Jeffery L. Painter, Christine M. Hunt, Heide A. Stirnadel-Farrant, Jie Cheng, (unknown), Kwan Lee	11
17	Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazar 2007 ·Pharmacogenetics and Genomics ·Colin F. Spraggs, Alun D. McCarthy, Linda McCarthy, Guizhu Hong, Arlene R. Hughes, Xiwu Lin, Ganesh M. Sathe, (unknown), Christopher Traini, Stephanie Van Horn, Liling Warren, Michael Mosteller	11
18	Genome-wide association studies using an adaptive two-stage analysis for a case-control design 2007 ·BMC Proceedings ·Kijoung Song, Qing Lu, Xiwu Lin, Dawn Waterworth, Robert C. Elston	3
19	Megavariate data analysis of mass spectrometric proteomics data using latent variable projection method 2003 ·PROTEOMICS ·(unknown), Xiwu Lin, (unknown), (unknown)	61
20	The Bias-Variance Tradeoff and the Randomized GACV 1998 ·neural information processing systems ·Grace Wahba, Xiwu Lin, (unknown), Dong Xiang, Ronald Klein	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact